Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

731081

	registered interest
	date	21/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many NHS staff members are from (1) EU member states other than the UK, and (2) countries outside the EU.
	tabling member printed	Lord Roberts of Llandudno
	uin	HL89
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>NHS Digital publishes data on the nationality of staff working in the National Health Service in England. Nationality is self-reported within the NHS human resources and payroll system, the electronic staff record.</p><p>As of 31 March 2017, latest data available, there are now 61,934 (headcount) European Union nationals (excluding the United Kingdom), or 5.2% employed in the NHS trusts and clinical commissioning groups. There are 75,450 other overseas nationals, or 6.4% employed in the NHS. 80,822 NHS staff records do not contain nationality data, with people either choosing not to specify their nationality or not asked to.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 15:50:03 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3691 label Biography information for Lord Roberts of Llandudno

731068

	registered interest
	date	21/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what change in funding in England for continued professional development for Registered Nurses took place in 2016/17; and what steps they are taking to address the situation.
	tabling member printed	Baroness Watkins of Tavistock
	uin	HL76
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Department does not hold this information centrally.</p><p><strong> </strong></p><p>Responsibility for ongoing post registration Professional Development lies with individual employers.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 15:10:37 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4566 label Biography information for Baroness Watkins of Tavistock

732746

	registered interest
	date	26/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government who advised the Commission on Human Medicines that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS) according to the Commission's minutes of 15–16 October 2015; and why this statement was made before the European Medicines Agency Scientific Advisory Group (SAG) reported on 21 October 2015.
	tabling member printed	The Countess of Mar
	uin	HL184
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>Following a review of human papillomavirus (HPV) vaccine safety on 16 July 2015, the CHM advised the MHRA that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS), as well as other chronic illnesses. The public minutes of this meeting were made available online on 18 November 2015.</p><p> </p><p>At its meeting on 15 October 2015, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of POTS and CRPS following HPV vaccine, in order to inform the United Kingdom position in the review. The public minutes of this meeting were made available online on 21 December 2015.</p><p> </p><p>The CHM did not make a statement in October in advance of the EMA’s Scientific Advisory Group meeting. The CHM’s minutes were published on the above dates in line with usual practice and have informed the MHRA’s responses to enquiries about the safety of HPV vaccine.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:05:33 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

732744

	registered interest
	date	26/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government, further to the Written Answer by the Parliamentary Under-Secretary of State, Department of Health, on 24 April (HC70973), when and how the Commission on Human Medicines "thoroughly review the data" on human papilloma virus (HPV) vaccine adverse reactions.
	tabling member printed	The Countess of Mar
	uin	HL182
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>The CHM considered a thorough review of the safety of human papillomavirus (HPV) vaccine at its meeting on 16 July 2015. Prior to 2015, the CHM considered reviews of HPV vaccine at meetings in September 2012, September 2010, September 2009, June 2009 and February 2009. These reviews included evaluation of United Kingdom Yellow Card reports, analysis of data from the Clinical Practice Research Datalink (CPRD), published safety studies and safety data from other countries.</p><p>Most recently, the CHM considered the safety of HPV vaccine at its meeting on 15 October 2015. At this meeting, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of postural orthostatic tachycardia syndrome and complex regional pain syndrome following HPV vaccine, in order to inform the UK position in the review.</p><p><strong> </strong>As with all vaccines and medicines, the safety of HPV vaccine remains under continual review by the MHRA.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:04:46 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar